Cancer Pain Management Market to Reach $8.39 Billion by 2032, Growing at a 5.4% CAGR

𝐓𝐡𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐩𝐚𝐢𝐧 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟓.𝟐𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟓.𝟓𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 𝐭𝐨 𝐔𝐒𝐃 𝟖.𝟑𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟒% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
Cancer pain management refers to the care given to a cancer patient during or after their cancer treatment in order to alleviate or reduce the pain that cancer treatment such as chemotherapy and other diagnostic procedures can cause them. Cancer patients may suffer from a host of symptoms such as muscle spasms and ostealgia, which is a type of bone pain or even necrosis. To combat these problems, patients can use noninvasive techniques such as meditation and imagery to dispel anxious and depressive thoughts. Medicinal drugs can also be used to treat painful symptoms of cancer. Acetaminophen and NSAIDs can be used for mild pain, opioids target more severe pain.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/cancer-pain-management-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬
• A large number of geriatric patients who are prone to cancer has resulted in the adoption of cancer pain treatment. Many cancer patients are showing their willingness to undergo treatments for cancer without having to go through the pain that comes along with these procedures. The pain is more serious in older patients as medication and dosage differ from the average adult age bracket.

• Advancement in technology has caused betterment in cancer pain management. The advent of gadgets such as wristwatches, which track internal processes such as heart rate and sleep patterns while also being aware of environmental conditions such as light and humidity, helps cancer patients who are sensitive to the slightest fluctuation in their surroundings.

𝐌𝐚𝐣𝐨𝐫 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬

Cancer pain management is a market that needs widespread awareness and many healthcare companies are echoing the same sentiment. Following is a list of companies who are at the forefront of the cancer pain management market.

• BioDelivery Sciences
• Daiichi Sankyo
• Eli Lilly & Company
• Endo Pharmaceuticals
• Johnson & Johnson Inc.
• Mallinckrodt Pharmaceuticals
• Pfizer Inc.
• Prostrakan Group
• Sanofi S.A.
• Teva Pharmaceuticals

𝐂𝐚𝐧𝐜𝐞𝐫 𝐏𝐚𝐢𝐧 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

• The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

• The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

• The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/cancer-pain-management-market/request-for-discount-pricing

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
• The cancer pain management is primarily segmented based on based on pain type, drug type, cancer type, application, end-use, and region.
• Based on drug type, opioids had the largest segment share due to its property od reducing severe pain in cancer patients.
• In terms of cancer type, lung cancer had the highest market share while breast cancer is the fastest growing segment with hypnotherapy and mindfulness being some of the cancer pain management techniques.

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)
 Acute Pain
 Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)
 Opioid
o Morphine
o Fentanyl
o Others
 Non-opioids
o Non-steroidal anti-inflammatory drug
o Acetaminophen
 Corticosteroids
 Anti-depressants
 Anti-anxiety drugs
 Anti-convulsant drugs
 Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)
 Lung Cancer
 Colorectal cancer
 Breast cancer
 Prostate cancer
 Blood cancer
 Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)
 Immunotherapy
 Chemotherapy
 Radiotherapy
 Home Therapy
 Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
 Hospitals
 Cancer Care Clinics
 Others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/cancer-pain-management-market

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
• North America (US, Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Hypertension Drug Market
https://www.polarismarketresearch.com/industry-analysis/global-hypertension-drug-market

Remote Patient Monitoring Devices Market
https://www.polarismarketresearch.com/industry-analysis/global-remote-patient-monitoring-devices-market

Anti-Snoring Devices and Snoring Surgery Market
https://www.polarismarketresearch.com/industry-analysis/global-anti-snoring-devices-and-snoring-surgery-market

Allergy Diagnostics and Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/global-allergy-diagnostics-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.